Clinical Trial Update: Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of flavopiridol for unresectable or metastatic kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED